- -

Neil Barrett1, Tanja A Gruber2, Takako Miyamura3

  • 1Department of Haematology, Children's Health Ireland, Dublin, Ireland.

PubMed
概括

婴儿急性淋巴细胞白血病 (ALL) 与KMT2A重组是积极的. 新型免疫疗法和针对性治疗,如blinatumomab提供新的希望,尽管挑战仍然存在.